Explore emerging targeted therapies for head and neck squamous cell carcinoma HNSCC with a focus on the evolving evidence for EGFRdirected bispecific antibodies This text module examines their mechanisms of action clinical development and potential role in addressing unmet treatment needs
Credit & MOC Details
Credit information is provided by the course provider. We recommend confirming credit eligibility with the provider or your licensing board before starting the activity.
Credit types
MOC types
FDA REMS
Qualifies for MIPS
Target Specialties
Address:
- 12001 Sunrise Valley Drive
Pricing
98% of listed courses are free
294 of a sample of 300 are free · 531 courses listed here.
Collected from the provider’s public pages · source
Specialties served/covered
- Addiction Medicine
- Advanced Heart Failure & Transplant Cardiology
- Allergy & Clinical Immunology
- Anatomic & Clinical Pathology
- Cardiovascular Disease
- Clinical Informatics
- Clinician Wellness & Burnout
- Communication & Shared Decision-Making
- Critical Care Medicine
- Dermatology
- Diagnostic Radiology
- Emergency Medicine
- Endocrinology, Diabetes & Metabolism
- Evidence-Based Medicine & Research
- Family Medicine
- Gastroenterology
- Gastrointestinal Surgery
- General & Adult Psychiatry
- General Internal Medicine
- General Pediatrics
- Geriatric Medicine
- Geriatric Psychiatry
- Head & Neck Surgery
- Health Equity & Inclusion
- Hematology
- Infectious Disease
- Laryngology
- Medical Genetics & Genomics
- Medical Leadership & Administration
- Medical Oncology
- Metabolic & Bariatric Surgery
- Mood & Anxiety Disorders
- Neonatal-Perinatal Medicine
- Nephrology
- Neurology
- Neuromuscular Medicine
- Neuroradiology
- Obstetrics & Gynecology
- Otology & Neurotology
- Pain Medicine
- Patient Education & Health Literacy
- Patient Safety & Quality Improvement
- Pediatric Hematology-Oncology
- Pediatric Infectious Diseases
- Pediatric Otolaryngology
- Psychopharmacology
- Psychotic Disorders
- Pulmonary Disease
- Rheumatology
- Sleep Medicine
- Surgical Oncology
- Thoracic Surgery
- Transplant Hepatology
- Cardio-Vascular
- Cross-Specialty
- Emergency & Critical Care
- ENT & Head Neck
- GI & Liver
- Infectious Disease
- Internal Medicine
- Medical Subspecialties
- Neurology
- Ob/Gyn
- Oncology & Hematology
- Pain & Palliative
- Pathology & Lab
- Pediatrics
- Primary care
- Psychiatry
- Radiology
- No reviews yet. Be the first to share yours.
Pricing
Free
Reported to ACCME by the provider
- On-demand / recorded video
- includes Online course / module
- Credit · Up to 0.25 credits
- Commercial Support
-
ReleasedJul 28, 2026
-
Last day to claim creditJan 28, 2027 4 months left
-
MedAll +1 Evolving Paradigms in Lung Cancer: Module 2 Rationale for PD-(L)1 x VEGF Bispecific Antibody Therapies
-
Plexus Communications +1 Contemporary B-ALL Care: Practical Integration and Use of CD19-Directed Bispecific Antibodies
-
PVI, PeerView Institute for Medical Education Building a Better Backbone for NSCLC and SCLC Treatment With PD-(L)1xVEGF-A Bispecific Antibodies: Inducing Immune Invigoration, Simplifying Treatment Delivery, and Enhancing Clinical Outcomes
-
Clinical Care Options, LLC (dba Decera Clinical Education) HNSCC: Current and Emerging Therapeutic Strategies
-
Clinical Care Options, LLC (dba Decera Clinical Education) Expert Guidance on Navigating the Evolving Head and Neck Cancer Treatment Continuum: What Matters Now and How to Apply It in Practice
-
Clinical Care Options, LLC (dba Decera Clinical Education) Advances in Bispecific Antibody Therapy for Multiple Myeloma: Strategies to Personalize Treatment and Elevate Patient Outcomes
